Elixinol Global is Growing the Top Line Driven by Elixinol and Expanding Operations

ACCESSWIRE - finance.yahoo.com Posted 5 years ago

NEW YORK, NY / ACCESSWIRE / December 11, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Elixinol Global Limited (ELLXF), a global presence in the cannabis industry including hemp-derived CBD dietary supplements, food and wellness products, as well as the cultivation and manufacture of medicinal cannabis products.

Since the end of October ELLXF share have gained significantly from $1.17 per share to the current price of $1.71. Trading volumes have also been increasing in step with the share price.

Financial data, growth drivers, company outlook and much more here READ MORE

Copy and paste to your browser may be required to view the report – https://tradersnewssource.com/elixinol-global/

The Company is closely monitoring ongoing 2018 Farm Bill legislative changes in the US which, if passed will strengthen the Elixinol USA business considerably and open up its ability to trade nationally and accelerate growth.

Significant business building initiatives have been put in place to increase cultivation and manufacturing capability for Elixinol in the US, including the NCHPP JV supply agreement and relocation to a new production facility to come on stream later this year in Colorado. The management expects growth in the Hemp Foods Australia business to be supported by launches of the company's own finished food products and penetration in the cosmetics segment through its SATIVA Skincare range.

Products, company and industry milestones plus much more in this report READ MORE

Copy and paste to your browser may be required to view the report – https://tradersnewssource.com/elixinol-global/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: [email protected]

SOURCE: Traders News Source